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Abstract
Objective To evaluate the prevalence of circumportal
pancreas (CP) and any coexisting anomaly. In addition,
three cases of surgically confirmed CP are presented.
Methods The study group consisted of 317 consecutive
potential liver transplant donor candidates who had under-
gone thin-section MDCT studies for the evaluation of
vascular anatomy. MDCT images were retrospectively
reviewed to assess the presence or absence of CP. If CP
was present, the transverse diameter of the aberrant
pancreatic tissue was measured on axial images, and the
course of the main pancreatic duct (MPD) was classified
into ante-portal (normal) or retro-portal. In addition, the
prevalence of variant hepatic arterial anatomy was com-
pared between cases with and without CP.
Results Eight of 317 liver transplant donor candidates (2.5%)
were found to have CP at CT. The transverse diameter of the
aberrant pancreatic tissue ranged from 5 to 18 mm (mean±
SD: 10±4 mm). One of eight (12.5%) showed the MPD to be
retro-portal.Avarianthepatic arterywasnotedintwooftheof
eight (25%) patients, which was similar to the finding for
those without CP [72 out of 309 (23%)].
Conclusion The prevalence of circumportal pancreas was
2.5%.
Keywords Pancreas.Anatomy.Anomaly.Pancreatic
surgery.MDCT
Introduction
Circumportal pancreas is a pancreatic anomaly, showing
complete pancreatic encasement of the portal vein above
the spleno-portal junction [1]. If circumportal pancreas is
present, additional resection of the aberrant pancreatic
tissue (i.e. anomalous connection between the dorsal and
ventral pancreas at the left side of the main portal vein) is
necessary for pancreatic head resection [2]. In addition, it
has been reported that circumportal pancreas may cause a
pancreatic fistula to emerge from the stump of aberrant
pancreatic tissue [2, 3]. It is therefore important to note the
presence of circumportal pancreas in patients for whom
pancreatic head resection is planned.
There have been only five previous literature reports
including eight cases of circumportal pancreas [1–5], and
this anomaly has been believed to be extremely rare.
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The purpose of this study was to evaluate the prevalence
of circumportal pancreas using thin-section multi-detector-
row computed tomography (MDCT) studies.
Materials and methods
The study group consisted of 317 consecutive liver transplant
donor candidates who had undergone contrast-enhanced
multi-detector row CT (MDCT) for the evaluation of vascular
anatomy between April 2006 and March 2010. There were
180 male and 137 female patients. Ages ranged from 19 to
64 years [mean±standard deviation (SD): 37±12 years old].
Contrast-enhanced MDCT studies were performed on a
64-detector-row MDCT (Aquilion; Toshiba Medical Sys-
tems, Tokyo, Japan) with a gantry rotation time of 0.5 s.
Each patient received intravenous (IV) non-ionic contrast
material. The dose of IV contrast material (maximum dose
of 150 ml) was determined based on the body weight:
1.71 ml/kg for 350 mg I/ml iohexol (Omnipaque 350;
Daiichi-Sankyo, Tokyo, Japan) and 1.62 ml/kg for 370 mg
I/ml iopamidol (Iopamiron 370; Bayer-Schering, Osaka,
Japan). IV contrast material was injected by means of an
automated power injector with an injection duration of 20 s
(maximum injection rate of 5 ml/s), and 20 ml of saline was
subsequently injected at the same injection rate. The patient
body weight, the dose of IV contrast and the injection rate
ranged from 37 to 90 kg (mean±SD: 59.8±10.3 kg), 62 to
146 ml (mean±SD: 97.7±15.9 ml) and 3.1 to 5.0 ml/s
(mean±SD: 4.6±0.5 ml/s), respectively. The CT parameters
were as follows: section collimation, 0.5 mm; helical pitch
53; 125 mAs; and 120 kVp. The arterial phase was
determined by the bolus tracking method. The region of
interest was established on the abdominal aorta at the level
of the celiac axis. The portal venous phase was obtained
70 s after the initiation of intravenous injection of contrast
agent. The section thicknesses of the arterial and portal
venous phases were 1 mm and 2 mm, respectively.
Two experienced radiologists reviewed 317 MDCT
studies to evaluate the presence or absence of circumportal
pancreas in a consensus fashion. Multiplanar reformatted
(MPR) images were obtained from the portal venous phase
by a three-dimensional (3D) computer workstation (Aqua-
riusNET; TeraRecon Inc., San Mateo, CA). Circumportal
pancreas was regarded as present when the main portal vein
above the level of the spleno-portal junction was completely
encircled by the pancreatic parenchyma on axial images, and
when aberrant pancreatic tissue extending behind the main
portalveinandfusingwiththepancreaticbodywasconfirmed
by MPR images created by the 3D workstation. If circum-
portal pancreas was present, the reviewers measured the
transverse diameter of the aberrant pancreatic tissue in the
axial plane. The measurements were performed twice,
and the average data were recorded. Additionally, the
course of the main pancreatic duct (MPD) was classified
into two types: ante-portal (normal) and retro-portal.
Furthermore, if a variant hepatic arterial anatomy was
present, it was recorded.
Results
Circumportal pancreas was noted in 8 of the 317 liver
transplant donor candidates (2.5%). In one case, one of the
reviewers mistakenly characterized circumportal pancreas
as the inferior edge of the caudate lobe of the liver. The
interobserver agreement was achieved in the remaining
seven cases. The transverse diameter of the aberrant
pancreatic tissue ranged from 5 mm to 18 mm [mean±
standard deviation (SD): 10±4 mm]. The transverse
diameter of the main portal vein (MPV) at the same level
ranged from 12 mm to 18 mm (mean±SD: 15±3 mm).
Narrowing of the MPV was not seen. These results are
summarized in Table 1. One of the eight (12.5%) showed
that the main pancreatic duct (MPD) ran behind the portal
vein (retroportal MPD; Fig. 1a). Other pancreatic ductal
anomalies such as pancreatic divisum were not observed in
any of these eight cases.
Age Sex Size (mm)
a Hepatic arterial anatomy Course of the MPD
31 M 5 mm Standard Ante-portal
27 M 13 mm Replaced LHA Ante-portal
31 M 12 mm Standard Ante-portal
26 M 8 mm Replaced RHA Ante-portal
31 F 10 mm Standard Ante-portal
52 F 11 mm Standard Ante-portal
54
b M 18 mm Standard Encasement of CHA Retro-portal
58 F 5 mm Standard Ante-portal
Table 1 Eight cases of circum-
portal pancreas in 317 liver
transplant donor candidates
aSize indicates the transverse di-
ameter of aberrant pancreatic tis-
sue.
bThis case is presented as
case 1. MPD=main pancreatic
duct. LHA=left hepatic artery.
RHA=right hepatic artery. CHA=
common hepatic artery
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variant hepatic arterial anatomy: a replaced right hepatic
artery (RHA) from the superior mesenteric artery (SMA)
(n=1) and a replaced left hepatic artery (LHA) from the left
gastric artery (LGA) (n=1), respectively. Additionally, in
one case the common hepatic artery (CHA) ran through the
pancreatic parenchyma, and encasement of the CHA was
also noted.
In liver transplant donor candidates without circumportal
pancreas, 72 out of 309 (23.3%) cases had variant hepatic
arterial anatomy, including the replaced/accessory RHA
(n=23), the accessory/replaced LHA (n=18), both the
replaced and accessory RHA, and the accessory and
replaced LHA (n=15), the hepatomesenteric trunk or
replaced proper hepatic artery (n=12), both the replaced
RHA and the replaced CHA (n=3), and the celiomesenteric
trunk (n=1). Therefore, the prevalence of variant hepatic
arteries was fairly similar to the prevalence of circumportal
pancreas.
Fig. 1 A 54-year-old male liver transplant donor candidate with
circumportal pancreas, retroportal main pancreatic duct and encase-
ment of the common hepatic artery. a Oblique axial multiplanar
reformatted (MPR) image obtained from the portal venous phase
shows encasement of the main portal vein (MPV) and the common
hepatic artery (CHA) by pancreatic parenchyma. b Oblique axial MPR
image obtained from the arterial phase demonstrates that the main
pancreatic duct (MPD) runs behind the MPV (retroportal MPD)
Fig. 2 A 45-year-old female patient with insulinoma of the pancreatic
head and circumportal pancreas. a The arterial phase of MDCT shows
a hypervascular pancreatic head tumor, consistent with insulinoma
(arrow). b The portal venous phase of axial MDCT demonstrates
aberrant pancreatic tissue (arrow) circumscribing the MPV. c
Photograph of the resected specimen from behind. Arrows indicate
aberrant pancreatic tissue
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Case 1
A 54-year-old man who was a liver transplant donor
candidate underwent MDCT for the evaluation of
vascular anatomy. MDCT showed circumportal pancreas
with a coexisting anomaly including a retroportal main
pancreatic duct and encasement of the common hepatic
artery (Fig. 1).
Case 2
A 45-year-old woman presented with loss of consciousness
due to hypoglycemia. Her serum blood sugar was 30 mg/dl
[normal range (NR): 69–109 mg/dl], and her immunoreac-
tive insulin (IRI) was 172.8 μU/ml (NR: 1.0–18.0 μU/ml).
Contrast-enhanced dynamic MDCT showed a 2-cm hyper-
vascular pancreatic head tumor, consistent with pancreatic
insulinoma (Fig. 2a). In retrospect, MDCT demonstrated
circumportal pancreas (Fig. 2b). Circumportal pancreas was
noticed during pancreatoduodenectomy. Additional resec-
tion of the aberrant pancreatic tissue was performed
(Fig. 2c). The postoperative course was uneventful.
Case 3
An 80-year-old patient underwent MDCT for postoperative
follow-up study. He had had a history of pancreatic head
resection with segmental duodenectomy for intraductal
papillary mucinous neoplasm (IPMN) 6 months previously
(Fig. 3). Follow-up MDCT demonstrated a 2-cm multi-
locular cystic mass at the posterior aspect of the portal vein
(Fig. 3d). Magnetic resonance cholangiopancreatography
(MRCP) showed the communication between the main
pancreatic duct and the cystic lesion (Fig. 3e). In retrospect,
preoperative MDCT showed circumportal pancreas
(Fig. 3b, c). We suspected that the cystic lesion represented
regrowth of residual IPMN. Surgical resection of the cystic
lesion was performed, and intraoperative findings showed
the cystic lesion to be connected to an aberrant pancreatic
tissue. The cystic lesion turned out to be a retention cyst
with granulation tissues. There was no residual IPMN
component.
Case 4
A 65-year-old asymptomatic male patient was discovered to
have elevated serum amylase levels and a pancreatic head
Fig. 3 An 80-year-old male patient with intraductal papillary
mucinous neoplasm (IPMN) of the pancreatic head and circumportal
pancreas. a Preoperative magnetic resonance cholangiopancreatogra-
phy (MRCP) shows multilocular cystic mass with dilatation of the
downstream main pancreatic duct (MPD) in the pancreatic head,
consistent with IPMN (large arrow). b The portal venous phase of
preoperative MDCT shows circumportal pancreas. IPMN component
extends to an aberrant pancreatic tissue (large arrow). c Sagittal
reformatted image obtained from the portal venous phase shows an
aberrant pancreatic tissue (arrow) above the splenoportal confluence
as well as IPMN. d Follow-up MDCT 6 months after the segmental
duodenectomy for IPMN demonstrates a 2-cm multilocular cystic
mass at the dorsal aspect of the portal vein (arrow). e Source image of
coronal MRCP shows the communication between the main pancre-
atic duct and the cystic lesion (arrow). The cystic lesion turned out to
be a retention cyst with granulation tissues
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U/l (NR: 42–132 U/l). Carcinoembryogenic antigen
(CEA) was 1.4 ng/ml (NR: ≤3.2 ng/ml), and carbohydrate
antigen 19–9 (CA 19–9) was 84.7 U/ml (NR: ≤37.0 U/mL).
MDCT revealed a 3-cm solid mass in the anterior portion of
the pancreatic head (Fig. 4a, b). There was a 2-cm
multilocular cystic mass in the posterior portion of the
pancreatic head (Fig. 4a, b). In addition, circumportal
pancreas was noted (Fig. 4c, d).
With the diagnosis of pancreatic head cancer and branch
duct-type IPMN, pylorus-preserving pancreatoduodenec-
tomy and additional resection of an aberrant pancreatic
tissue were performed. Circumportal pancreas was con-
firmed surgically (Fig. 4e). The postoperative course was
uneventful. The pathological diagnosis was pancreatic head
adenocarcinoma and benign intraductal papillary mucinous
adenoma.
Discussion
Our study showed that 2.5% of liver transplant donor
candidates (8 out of 317) had circumportal pancreas. This
result suggests that the prevalence of circumportal pancreas is
not extremely low. This anomaly has not received adequate
attention in preoperative imaging studies. If an aberrant
pancreatic tissue is small, it may be difficult to spot during
the surgical procedure. In addition, the degree of pancreatic
fistula from a small aberrant pancreatic tissue may be
subclinical if drainage tubes are placed appropriately.
The embryogenesis of the pancreas is complex. The
ventral pancreatic primordium rotates and fuses with the
dorsal pancreatic primordium. Circumportal pancreas may
result from the higher fusion of both primordia above the
level of the spleno-portal junction. Interestingly, in one
case, the common hepatic artery ran through the pancreatic
head. It may also result from higher fusion of the ventral
and dorsal pancreatic primordia.
In one of the eight circumportal pancreas cases
(12.5%), the main pancreatic duct (MPD) was seen
behind the main portal vein (retroportal MPD). Retro-
portal MPD was reported in three of the eight previously
reported circumportal pancreas cases (37.5%) [3, 4].
Awareness of this coexisting anomaly is important for
pancreatic resection because of the substantial risk of
pancreatic fistula [3]. Although the mechanism of the
development of retroportal MPD is unclear, it may be
related to the large size of aberrant pancreatic tissue (i.e.
Fig. 4 A 45-year-old male patient with pancreatic head cancer, IPMN
and circumportal pancreas. a The arterial phase of MDCT shows a
hypoattenuating mass in the anterior portion of the pancreatic head,
consistent with pancreatic cancer (CA). A cystic mass is seen in the
posterior portion of the pancreatic head, representing pancreatic IPMN
(IPMN). b MRCP shows a multilocular cystic mass, consistent with
IPMN (black arrow). Obstruction of the main pancreatic duct by
pancreatic head cancer is demonstrated (white arrow). c The portal
venous phase of MDCT above the level of the spleno-portal junction
shows encasement of the main portal vein, representing circumportal
pancreas. Arrow indicates an aberrant pancreatic tissue. Dilatation of
the main pancreatic duct is seen. d Coronal reformatted image
obtained from the portal venous phase shows an aberrant pancreatic
tissue above the splenoportal confluence (arrow). e Intraoperative
finding. An aberrant pancreatic tissue is noted behind the main portal
vein (arrow). Ph=pancreatic head. Pb=pancreatic body. MPV=main
portal vein. SpV=splenic vein. PHA=proper hepatic artery
Insights Imaging (2011) 2:409–414 413the large size of the ventral pancreas behind the main
portal vein may increase the chance of a retroportal course
of the Wirsung's duct).
In our series, two of the eight donor candidates with
circumportal pancreas (25%) had variant hepatic arteries,
and the prevalence of variant hepatic arteries was similar to
that without circumportal pancreas (23.4%). This result
suggests that there is no association between circumportal
pancreas and variant hepatic arteries.
The differential diagnoses of circumportal pancreas may
include peripancreatic lymphadenopathy and the inferior
edge of the caudate lobe of the liver. Although we did not
have surgical confirmation from liver transplant donor
candidates, we believe that multiplanar reformatted (MPR)
images obtained from the thin-section MDCT were suffi-
cient to prove the presence or absence of circumportal
pancreas.
In conclusion, circumportal pancreas is not extremely
rare. Care should be taken regarding the presence or
absence of circumportal pancreas in patients for whom
pancreatic head resection is planned.
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